Form 4 for CRMD CorMedix Inc.

Accepted 2024-01-17 00:00:00 ET · period of report 2024-01-12 · accession 0000929638-24-000134 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-17	2024-01-12	CRMD	Masson-Hurlburt Elizabeth	EVP, Head of Clinical Ops	F - Tax	$3.47	-4,603	53.4K	-8%	-$16.0K
D	2024-01-17	2024-01-12	CRMD	Masson-Hurlburt Elizabeth	EVP, Head of Clinical Ops	A - Grant	$0.00	+50.0K	58.0K	+625%	$0
D	2024-01-17	2024-01-12	CRMD	Masson-Hurlburt Elizabeth	EVP, Head of Clinical Ops	A - Grant	$0.00	+100.0K	100.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-12	F	D	4,603	$3.47	53,397	D	—	—
2	Common	Common Stock	2024-01-12	A	A	50,000	$0.00	58,000	D	—	—	(F1) These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
3	Derivative	Stock Option (Right to Buy Common Stock)	2024-01-12	A	A	100,000	$0.00	100,000	D	$3.47 · — to 2034-01-11	100,000 Common Stock	(F2) These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.